CLGN logo

CLGN Cash From Investing

Annual CFI

-$1.16 M
-$30.08 M-104.00%

December 31, 2023

Summary

Performance

1-Year Change

-104%

3-Year Change

-122.74%

5-Year Change

-38.94%

15-Year Change

-810.24%

CLGN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.38%
CLGN annual cash flow from investing activities is higher than 43.38% of companies in Healthcare sector

High & Low

All-time High

$28.92 M
CLGN annual cash flow from investing activities is currently -104.00% below its historical high of $28.92 million

3-Year Low

-$31.56 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CLGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 4, 2025
CLGN next annual earnings announcement is scheduled for Apr 4, 2025

OtherCLGNcash flowmetrics:

Annual CFF

$1.11 M
CLGN annual cash flow from financing activities is $1.11 million

Annual CFO

-$2.76 M
CLGN annual cash flow from operations is -$2.76 million

Annual FCF

-$3.72 M
CLGN annual free cash flow is -$3.72 million

Annual CAPEX

$954.00 K
CLGN annual capital expenditures is $954.00 thousand

Quarterly CFI

-$140.00 K
+$119.00 K+45.95%

September 30, 2024

Summary

Performance

3-Month Change

+45.95%

1-Year Change

+42.39%

3-Year Change

+42.39%

5-Year Change

+42.39%

CLGN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.81%
CLGN quarterly cash flow from investing activities is higher than 41.81% of companies in Healthcare sector

High & Low

All-time High

$29.89 M
CLGN quarterly cash flow from investing activities is currently -100.47% below its historical high of $29.89 million

3-Year Low

-$10.47 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CLGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 4, 2025
CLGN next earnings announcement is scheduled for Apr 4, 2025

OtherCLGNcash flowmetrics:

Quarterly CFF

$0.00
CLGN quarterly cash flow from financing activities is $0.00

Quarterly CFO

-$3.45 M
CLGN quarterly cash flow from operations is -$3.45 million

Quarterly FCF

-$3.59 M
CLGN quarterly free cash flow is -$3.59 million

Quarterly CAPEX

$140.00 K
CLGN quarterly capital expenditures is $140.00 thousand

TTM CFI

-$853.00 K
+$103.00 K+10.77%

September 30, 2024

Summary

Performance

3-Month Change

+10.77%

1-Year Change

+21.6%

3-Year Change

+21.6%

5-Year Change

+21.6%

CLGN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.65%
CLGN TTM cash flow from investing activities is higher than 45.65% of companies in Healthcare sector

High & Low

All-time High

$28.92 M
CLGN TTM cash flow from investing activities is currently -102.95% below its historical high of $28.92 million

3-Year Low

-$31.56 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CLGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 4, 2025
CLGN next earnings announcement is scheduled for Apr 4, 2025

OtherCLGNcash flowmetrics:

TTM CFF

$9000.00
CLGN TTM cash flow from financing activities is $9000.00

TTM CFO

-$12.97 M
CLGN TTM cash flow from operations is -$12.97 million

TTM FCF

-$13.63 M
CLGN TTM free cash flow is -$13.63 million

TTM CAPEX

$653.00 K
CLGN TTM capital expenditures is $653.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CLGN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-104.0%+42.4%+21.6%
3 y3 years-122.7%+42.4%+21.6%
5 y5 years-38.9%+42.4%+21.6%

CLGN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-104.0%+96.3%-100.5%+98.7%-103.0%+97.3%
5 y5-year-104.0%+96.3%-100.5%+99.5%-103.0%+97.3%
alltimeall time-104.0%+96.3%-100.5%+99.5%-103.0%+97.3%

CollPlant Biotechnologies Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$140.00 K(-45.9%)
-$853.00 K(-10.8%)
Jun 2024
-
-$259.00 K(+215.9%)
-$956.00 K(-12.5%)
Mar 2024
-
-$82.00 K(-78.0%)
-$1.09 M(-5.4%)
Dec 2023
-$1.16 M(-104.0%)
-$372.00 K(+53.1%)
-$1.16 M(+6.3%)
Sep 2023
-
-$243.00 K(-38.6%)
-$1.09 M(-6.8%)
Jun 2023
-
-$396.00 K(+173.1%)
-$1.17 M(+5.3%)
Mar 2023
-
-$145.00 K(-52.3%)
-$1.11 M(-103.8%)
Dec 2022
$28.92 M(-191.7%)
-$304.00 K(-5.6%)
$28.92 M(+54.2%)
Sep 2022
-
-$322.00 K(-4.5%)
$18.75 M(-34.1%)
Jun 2022
-
-$337.00 K(-101.1%)
$28.44 M(-0.2%)
Mar 2022
-
$29.89 M(-385.3%)
$28.51 M(-190.3%)
Dec 2021
-$31.56 M(+5980.2%)
-
-
Dec 2021
-
-$10.47 M(-211.8%)
-$31.56 M(+48.7%)
Sep 2021
-
$9.37 M(-3594.4%)
-$21.22 M(-30.9%)
Jun 2021
-
-$268.00 K(-99.1%)
-$30.72 M(+0.3%)
Mar 2021
-
-$30.18 M(>+9900.0%)
-$30.61 M(+5798.5%)
Dec 2020
-$519.00 K(-64.5%)
-
-
Dec 2020
-
-$141.00 K(+6.8%)
-$519.00 K(-24.2%)
Sep 2020
-
-$132.00 K(-18.0%)
-$685.00 K(+5.9%)
Jun 2020
-
-$161.00 K(+89.4%)
-$647.00 K(-22.5%)
Mar 2020
-
-$85.00 K(-72.3%)
-$835.00 K(-42.8%)
Dec 2019
-$1.46 M
-
-
Dec 2019
-
-$307.00 K(+226.6%)
-$1.46 M(+17.5%)
Sep 2019
-
-$94.00 K(-73.1%)
-$1.24 M(-0.2%)
Jun 2019
-
-$349.00 K(-50.9%)
-$1.25 M(-6.7%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$711.00 K(+698.9%)
-$1.33 M(+60.5%)
Dec 2018
-$832.00 K(+555.1%)
-
-
Dec 2018
-
-$89.00 K(-8.2%)
-$832.00 K(-2.6%)
Sep 2018
-
-$97.00 K(-77.9%)
-$854.10 K(+12.4%)
Jun 2018
-
-$438.00 K(+110.6%)
-$760.10 K(+134.8%)
Mar 2018
-
-$208.00 K(+87.2%)
-$323.70 K(+154.9%)
Dec 2017
-$127.00 K(-0.7%)
-
-
Dec 2017
-
-$111.10 K(+3603.3%)
-$127.00 K(-1630.1%)
Sep 2017
-
-$3000.00(+87.5%)
$8300.00(-110.1%)
Jun 2017
-
-$1600.00(-85.8%)
-$81.90 K(-18.8%)
Mar 2017
-
-$11.30 K(-146.7%)
-$100.80 K(-21.2%)
Dec 2016
-$127.90 K(-64.1%)
-
-
Dec 2016
-
$24.20 K(-126.0%)
-$127.90 K(-38.2%)
Sep 2016
-
-$93.20 K(+354.6%)
-$207.10 K(+37.7%)
Jun 2016
-
-$20.50 K(-46.6%)
-$150.40 K(-40.6%)
Mar 2016
-
-$38.40 K(-30.2%)
-$253.20 K(-28.8%)
Dec 2015
-$355.80 K(+248.8%)
-
-
Dec 2015
-
-$55.00 K(+50.7%)
-$355.80 K(-84.7%)
Sep 2015
-
-$36.50 K(-70.4%)
-$2.33 M(+1.6%)
Jun 2015
-
-$123.30 K(-12.6%)
-$2.29 M(-25.1%)
Mar 2015
-
-$141.00 K(-93.0%)
-$3.06 M(+4.8%)
Dec 2014
-$102.00 K(-10.5%)
-
-
Dec 2014
-
-$2.03 M(+127.0%)
-$2.92 M(+227.0%)
Jun 2014
-
-$893.30 K
-$893.30 K
Dec 2013
-$114.00 K(-22.9%)
-
-
Dec 2012
-$147.80 K
-
-

FAQ

  • What is CollPlant Biotechnologies annual cash flow from investing activities?
  • What is the all time high annual CFI for CollPlant Biotechnologies?
  • What is CollPlant Biotechnologies annual CFI year-on-year change?
  • What is CollPlant Biotechnologies quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for CollPlant Biotechnologies?
  • What is CollPlant Biotechnologies quarterly CFI year-on-year change?
  • What is CollPlant Biotechnologies TTM cash flow from investing activities?
  • What is the all time high TTM CFI for CollPlant Biotechnologies?
  • What is CollPlant Biotechnologies TTM CFI year-on-year change?

What is CollPlant Biotechnologies annual cash flow from investing activities?

The current annual CFI of CLGN is -$1.16 M

What is the all time high annual CFI for CollPlant Biotechnologies?

CollPlant Biotechnologies all-time high annual cash flow from investing activities is $28.92 M

What is CollPlant Biotechnologies annual CFI year-on-year change?

Over the past year, CLGN annual cash flow from investing activities has changed by -$30.08 M (-104.00%)

What is CollPlant Biotechnologies quarterly cash flow from investing activities?

The current quarterly CFI of CLGN is -$140.00 K

What is the all time high quarterly CFI for CollPlant Biotechnologies?

CollPlant Biotechnologies all-time high quarterly cash flow from investing activities is $29.89 M

What is CollPlant Biotechnologies quarterly CFI year-on-year change?

Over the past year, CLGN quarterly cash flow from investing activities has changed by +$103.00 K (+42.39%)

What is CollPlant Biotechnologies TTM cash flow from investing activities?

The current TTM CFI of CLGN is -$853.00 K

What is the all time high TTM CFI for CollPlant Biotechnologies?

CollPlant Biotechnologies all-time high TTM cash flow from investing activities is $28.92 M

What is CollPlant Biotechnologies TTM CFI year-on-year change?

Over the past year, CLGN TTM cash flow from investing activities has changed by +$235.00 K (+21.60%)